Scrip
US FDA orders boxed warnings on toxin spread for Botox and Myobloc
01 May 2009
Sue Sutter
The US
FDA has ordered "black box" warnings and risk evaluation and mitigation strategies (REMS) for all botulinum toxin products regarding the risk of adverse effects when the toxin spreads beyond the injection site.
The agency's directive, issued under the drug safety authorities of the FDA...
Please Login to read the full article.
01 May 2009
Sue Sutter
The agency's directive, issued under the drug safety authorities of the FDA...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
EVENTS
Today
Berlin, Germany
Today
Berlin, Germany
22 March 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
